[
    "{\"step_by_step_thinking\": \"According to the relevant documents, Strimvelis has been approved by the European Medicines Agency (EMA). Document [0] mentions that Strimvelis was recommended for marketing approval by a committee at the EMA and was subsequently approved by the European Commission. Document [3] also states that Strimvelis is the first ex vivo autologous gene therapy approved by the EMA. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]